MedTrace Logo

MRE as a Screening Tool for axSpA in IBD

NCT03817983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 259

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

This study aims to assess the effectiveness (specificity and sensitivity) of using magnetic resonance enterography (MRE) as a screening tool for axial spondyloarthritis (axSpA) in patients with Crohns disease. Patients with evidence of axSpA on MRE imaging will be assessed clinically for axSpA (including a dedicated axial magnetic resonance imaging scan of the spine and sacroiliac joints) and will be compared to a group of age and sex-matched control participants with Crohn's disease but with no evidence of axSpA on MRE imaging.

Conditions

  • Axial Spondyloarthritis
  • Crohn Disease

Interventions

DIAGNOSTIC_TEST

MRE review for evidence of axSpA in SIJs

Screening for evidence of axSpA on the MRE scan of patients with Crohn's disease

DIAGNOSTIC_TEST

Clinical assessment and dedicated MRI of the spine and pelvis

Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA

Sponsors & Collaborators

Principal Investigators

  • Deepak R Jadon, MBBCh PhD · CUH NHSFT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2020-08-08
Completion
2020-08-08

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817983 on ClinicalTrials.gov